| Title： | Guideline for the management of diabetes mellitus in the elderly in China (2024 edition) |
| Edition： | Updated |
| Classification： | Standard guideline |
| Field： | Comprehensive guideline |
| Countries and regions： | China |
| Guidelines users： | Endocrinologist, Geriatrician and General Practitioner |
| Evidence classification method： | The evidence level is classified into A, B, and C. Evidence level A: The evidence is based on multiple randomized controlled trials or Meta-analysis. Evidence level B: The evidence is based on a single randomized controlled trial or multiple non-randomized controlled studies. Evidence level C: It is only expert consensus and/or based on small-scale studies, retrospective studies, and results from registries. |
| Development unit： | National Center of Gerontology, Chinese Society of Geriatrics, Diabetes Professional Committee of Chinese Aging Well Association |
| Registration time: | 2023-11-19 |
| Registration number： | PREPARE-2023CN921 |
| Purpose of the guideline: | With the intensification of aging in our country and the increasing management needs of elderly patients with diabetes, there is an urgent need to standardize the management of elderly diabetes patients. In 2021, we issued the first authoritative domestic guidelines on the management of elderly diabetes, which had high readership and download rates, ranking among the top guidelines of the same period. In the past three years, new basic and clinical research has emerged in the field of elderly diabetes, including the introduction of new drugs for controlling diabetes and its complications. The evidence from clinical studies related to elderly diabetes has accumulated. Based on this, the National Center of Gerontology, Chinese Society of Geriatrics, and Diabetes Professional Committee of Chinese Aging Well Association organized well-known domestic experts in the fields of diabetes, geriatric diseases, and related areas to jointly update the "Guideline for the management of diabetes mellitus in the elderly in China (2021 edition)" and write the "Guideline for the management of diabetes mellitus in the elderly in China (2024 edition)" with the aim of guiding and assisting clinicians in the comprehensive standardized management of elderly diabetes patients in China throughout the entire care cycle, and improving the clinical outcomes of elderly diabetes patients in China. |
